HUP0200608A3 - Heterocyclic compounds, intermediates thereof and elastase inhibitors and pharmaceutical compositions containing them - Google Patents
Heterocyclic compounds, intermediates thereof and elastase inhibitors and pharmaceutical compositions containing themInfo
- Publication number
- HUP0200608A3 HUP0200608A3 HU0200608A HUP0200608A HUP0200608A3 HU P0200608 A3 HUP0200608 A3 HU P0200608A3 HU 0200608 A HU0200608 A HU 0200608A HU P0200608 A HUP0200608 A HU P0200608A HU P0200608 A3 HUP0200608 A3 HU P0200608A3
- Authority
- HU
- Hungary
- Prior art keywords
- intermediates
- pharmaceutical compositions
- compositions containing
- heterocyclic compounds
- elastase inhibitors
- Prior art date
Links
- 239000003602 elastase inhibitor Substances 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11056052A JP2000256396A (ja) | 1999-03-03 | 1999-03-03 | 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200608A2 HUP0200608A2 (en) | 2002-08-28 |
| HUP0200608A3 true HUP0200608A3 (en) | 2002-09-30 |
Family
ID=13016323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200608A HUP0200608A3 (en) | 1999-03-03 | 2000-02-23 | Heterocyclic compounds, intermediates thereof and elastase inhibitors and pharmaceutical compositions containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6835714B1 (enExample) |
| EP (1) | EP1157998B1 (enExample) |
| JP (1) | JP2000256396A (enExample) |
| KR (1) | KR100622709B1 (enExample) |
| CN (1) | CN1183156C (enExample) |
| AT (1) | ATE259376T1 (enExample) |
| AU (1) | AU758739B2 (enExample) |
| CA (1) | CA2362911A1 (enExample) |
| DE (1) | DE60008218T2 (enExample) |
| DK (1) | DK1157998T3 (enExample) |
| ES (1) | ES2215608T3 (enExample) |
| HK (1) | HK1044955B (enExample) |
| HU (1) | HUP0200608A3 (enExample) |
| IL (2) | IL144813A0 (enExample) |
| MX (1) | MXPA01008836A (enExample) |
| NZ (1) | NZ513594A (enExample) |
| PL (1) | PL199136B1 (enExample) |
| PT (1) | PT1157998E (enExample) |
| RU (1) | RU2222539C2 (enExample) |
| TR (1) | TR200102540T2 (enExample) |
| TW (1) | TW534905B (enExample) |
| WO (1) | WO2000052032A1 (enExample) |
| ZA (1) | ZA200106514B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2289887A3 (en) | 2000-06-30 | 2011-07-06 | Seikagaku Corporation | Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them |
| AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
| SK742003A3 (en) | 2000-07-21 | 2003-06-03 | Schering Corp | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| US7012066B2 (en) * | 2000-07-21 | 2006-03-14 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| GB0021315D0 (en) | 2000-08-30 | 2000-10-18 | Dainippon Pharmaceutical Co | Heterocyclic compounds and intermediates thereof |
| WO2002026229A1 (en) * | 2000-09-29 | 2002-04-04 | Ono Pharmaceutical Co., Ltd. | Airway mucus secretion inhibitors |
| PL371539A1 (en) * | 2002-02-05 | 2005-06-27 | Dainippon Pharmaceutical Co, Ltd. | Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| ATE438622T1 (de) * | 2004-02-27 | 2009-08-15 | Schering Corp | 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus |
| EP2019837B1 (en) * | 2006-05-23 | 2011-03-23 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| EP2027143A2 (en) * | 2006-05-23 | 2009-02-25 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| WO2008032331A1 (en) * | 2006-09-12 | 2008-03-20 | Himalaya Global Holdings Ltd. | Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof |
| CA2677485A1 (en) * | 2007-02-09 | 2008-08-14 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| CA2677487A1 (en) * | 2007-02-09 | 2008-08-14 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| US9353113B2 (en) | 2011-03-18 | 2016-05-31 | Ono Pharmaceutical Co., Ltd. | Tetrahydrocarboline derivative |
| CN104031014B (zh) * | 2013-03-08 | 2016-05-11 | 华中师范大学 | 香豆素衍生物及其制备方法以及弹性蛋白酶活性检测方法和检测试剂盒 |
| CN104165869B (zh) * | 2013-05-17 | 2016-12-28 | 华中师范大学 | 一种检测蛋白水解酶活性的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS231228B1 (en) | 1982-10-01 | 1984-10-15 | Evzen Kasafirek | Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method |
| GB8600263D0 (en) | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
| GB8809316D0 (en) | 1987-05-11 | 1988-05-25 | Ici America Inc | Heterocyclic ketones |
| CA1340191C (en) | 1988-06-13 | 1998-12-15 | Katsuhiro Imaki | Derivatives of p-substituted phenyl ester of pivalic acid |
| IT1245712B (it) * | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
| IT1255704B (it) * | 1992-09-30 | 1995-11-10 | Boehringer Mannheim Italia | Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree |
| US5565568A (en) * | 1995-04-06 | 1996-10-15 | Eli Lilly And Company | 2-acylaminopropanamides as tachykinin receptor antagonists |
-
1999
- 1999-03-03 JP JP11056052A patent/JP2000256396A/ja active Pending
-
2000
- 2000-02-23 CA CA002362911A patent/CA2362911A1/en not_active Abandoned
- 2000-02-23 IL IL14481300A patent/IL144813A0/xx active IP Right Grant
- 2000-02-23 TR TR2001/02540T patent/TR200102540T2/xx unknown
- 2000-02-23 HU HU0200608A patent/HUP0200608A3/hu unknown
- 2000-02-23 WO PCT/JP2000/001022 patent/WO2000052032A1/ja not_active Ceased
- 2000-02-23 ES ES00905282T patent/ES2215608T3/es not_active Expired - Lifetime
- 2000-02-23 CN CNB008070636A patent/CN1183156C/zh not_active Expired - Fee Related
- 2000-02-23 EP EP00905282A patent/EP1157998B1/en not_active Expired - Lifetime
- 2000-02-23 AT AT00905282T patent/ATE259376T1/de not_active IP Right Cessation
- 2000-02-23 DE DE60008218T patent/DE60008218T2/de not_active Expired - Fee Related
- 2000-02-23 AU AU26902/00A patent/AU758739B2/en not_active Ceased
- 2000-02-23 MX MXPA01008836A patent/MXPA01008836A/es active IP Right Grant
- 2000-02-23 NZ NZ513594A patent/NZ513594A/xx unknown
- 2000-02-23 HK HK02106283.1A patent/HK1044955B/zh not_active IP Right Cessation
- 2000-02-23 KR KR1020017011031A patent/KR100622709B1/ko not_active Expired - Fee Related
- 2000-02-23 DK DK00905282T patent/DK1157998T3/da active
- 2000-02-23 PT PT00905282T patent/PT1157998E/pt unknown
- 2000-02-23 RU RU2001126725/04A patent/RU2222539C2/ru not_active IP Right Cessation
- 2000-02-23 PL PL349709A patent/PL199136B1/pl not_active IP Right Cessation
- 2000-02-23 US US09/913,538 patent/US6835714B1/en not_active Expired - Fee Related
- 2000-02-25 TW TW089103336A patent/TW534905B/zh not_active IP Right Cessation
-
2001
- 2001-08-08 IL IL144813A patent/IL144813A/en not_active IP Right Cessation
- 2001-08-08 ZA ZA200106514A patent/ZA200106514B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1044955B (zh) | 2005-07-08 |
| CN1183156C (zh) | 2005-01-05 |
| KR100622709B1 (ko) | 2006-09-13 |
| RU2222539C2 (ru) | 2004-01-27 |
| PT1157998E (pt) | 2004-06-30 |
| EP1157998B1 (en) | 2004-02-11 |
| AU758739B2 (en) | 2003-03-27 |
| EP1157998A4 (en) | 2003-01-29 |
| IL144813A (en) | 2006-12-10 |
| KR20020002396A (ko) | 2002-01-09 |
| JP2000256396A (ja) | 2000-09-19 |
| CA2362911A1 (en) | 2000-09-08 |
| US6835714B1 (en) | 2004-12-28 |
| ES2215608T3 (es) | 2004-10-16 |
| HK1044955A1 (en) | 2002-11-08 |
| TW534905B (en) | 2003-06-01 |
| DE60008218T2 (de) | 2004-12-09 |
| TR200102540T2 (tr) | 2002-01-21 |
| MXPA01008836A (es) | 2002-05-14 |
| NZ513594A (en) | 2003-04-29 |
| IL144813A0 (en) | 2002-06-30 |
| DK1157998T3 (da) | 2004-06-14 |
| EP1157998A1 (en) | 2001-11-28 |
| ZA200106514B (en) | 2002-05-10 |
| HUP0200608A2 (en) | 2002-08-28 |
| CN1349542A (zh) | 2002-05-15 |
| ATE259376T1 (de) | 2004-02-15 |
| AU2690200A (en) | 2000-09-21 |
| WO2000052032A1 (en) | 2000-09-08 |
| DE60008218D1 (de) | 2004-03-18 |
| PL199136B1 (pl) | 2008-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL158168A0 (en) | 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same | |
| HU228254B1 (en) | 5-membered heteroaromatic compound and pharmaceutical compositions containing it | |
| HUP0200347A2 (en) | N-cyanomethylamides as protease inhibitors, pharmaceutical compositions containing them and their use | |
| IL191960A0 (en) | Heterocyclic aromatic compounds and pharmaceutical compositions containing the same | |
| HUP0402236A3 (en) | Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| HUP0400058A2 (hu) | Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0401898A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| IL144592A0 (en) | Heterocyclic aromatic compounds and pharmaceutical compositions containing the same | |
| IL145428A0 (en) | Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL162547A0 (en) | Fused heterocyclic succinimide derivatives and pharmaceutical compositions containing the same | |
| IL157131A0 (en) | Nitrogen containing heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
| EP1405859A4 (en) | NITROGENIC HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, MEDICAL USE AND INTERMEDIATE PRODUCTS CONTAINING THEREOF | |
| HUP0401900A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| HUP0302226A3 (en) | Substituted pyrrolopyridinone dervatives useful as phosphodiesterse inhibitors, their intermediates and pharmaceutical compositions containing the compounds | |
| HUP0200155A3 (en) | Thioamide derivatives, pharmaceutical compositions containing them and their use | |
| HUP0202520A3 (en) | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them | |
| IL158898A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF | |
| IL157740A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., JP Free format text: FORMER OWNER(S): DAINIPPON PHARMACEUTICAL CO. LTD., JP |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |